Evidence map›Paper›PMID 9122220›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130.

A Kumanogoh, S Marukawa, T Kumanogoh, H Hirota, K Yoshida, I S Lee, T Yasui, K Yoshida, T Taga, T Kishimoto

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Silencing of B cell receptor signals in human naive B cells.The Journal of experimental medicine · 2002
    Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

A KumanogohDepartment of Medicine III, Osaka University Medical School, Yamada-oka, Suita, Japan.
S Marukawa
T Kumanogoh
H Hirota
K Yoshida
I S Lee
T Yasui
K Yoshida
T Taga
T Kishimoto
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

gp130 is a common signal-transducing receptor component for the interleukin 6 family of cytokines functioning in, for example, immune, hematopoietic, and nervous systems. In this study, to investigate the physiological functions of gp130 and to determine the pathological consequences of impaired gp130 signals, we have generated transgenic mice expressing a cytoplasmically truncated form of mouse gp130. Expression of this form of gp130 in lymphocytes significantly suppressed interleukin 6-induced tyrosine phosphorylation of endogenous gp130 and a downstream signaling molecule, signal transducer and activator of transcription 3, indicating that this form has a dominant negative function. In spite of the impaired gp130 signals, the development of lymphocytes in the transgenic mice appeared normal in terms of surface marker phenotypes. These mice, however, exhibited severe defects in antigen-specific antibody production of most immunoglobulin isotypes other than IgM after immunization with 2,4-dinitrophenol-conjugated ovalbumin. These results demonstrate in vivo that gp130 is essential for antigen-specific antibody production.

Indexed as

Antibody FormationActinsAnimalsAntigens, CDB-LymphocytesChickensCytokine Receptor gp130DinitrophenolsDNA-Binding ProteinsGenes, DominantHaptensInterleukin-6Membrane GlycoproteinsMiceMice, Inbred C57BLMice, TransgenicActinsAntigens, CDCytokine Receptor gp130dinitrophenol-ovalbuminDinitrophenolsDNA-Binding ProteinsHaptensIl6st protein, mouseInterleukin-6Membrane GlycoproteinsOvalbuminStat3 protein, mouseSTAT3 Transcription FactorTrans-Activators

Identifiers

PMID9122220
PMCPMC20113
OpenAlexW2048545509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.